Literature DB >> 11067973

Analysis of single K(ATP) channels in mammalian dentate gyrus granule cells.

M R Pelletier1, P A Pahapill, P S Pennefather, P L Carlen.   

Abstract

ATP-sensitive potassium (K(ATP)) channels are heteromultimer complexes of subunits from members of the inwardly rectifying K(+) channel and the ATP-binding cassette protein superfamilies. K(ATP) channels couple metabolic state to membrane excitability, are distributed widely, and participate in a variety of physiological functions. Understood best in pancreatic beta cells, where their activation inhibits insulin release, K(ATP) channels have been implicated also in postischemia cardio- and neuroprotection. The dentate gyrus (DG) is a brain region with a high density of K(ATP) channels and is relatively resistant to ischemia/reperfusion-induced cell death. Therefore we were interested in describing the characteristics of single K(ATP) channels in DG granule cells. We recorded single K(ATP) channels in 59/105 cell-attached patches from DG granule cells in acutely prepared hippocampal slices. Single-channel openings had an E(K) close to 0 mV (symmetrical K(+)) and were organized in bursts with a duration of 19.3 +/- 1.6 (SE) ms and a frequency of 3.5 +/- 0.8 Hz, a unitary slope conductance of 27 pS, and a low, voltage-independent, probability of opening (P(open), 0.04 +/- 0.01). Open and closed dwell-time histograms were fitted best with one (tau(open) = 1.3 +/- 0.2 ms) and the sum of two (tau(closed,fast) = 2.6 +/- 0.9 ms, tau(closed,slow) = 302.7 +/- 67. 7 ms) exponentials, respectively, consistent with a kinetic model having at least a single open and two closed states. The P(open) was reduced ostensibly to zero by the sulfonylureas, glybenclamide (500 nM, 2/6; 10 microM,11/14 patches) and tolbutamide (20 microM, 4/6; 100 microM, 4/4 patches). The blocking dynamics for glybenclamide included transition to a subconductance state (43.3 +/- 2.6% of control I(open channel)). Unlike glybenclamide, the blockade produced by tolbutamide was reversible. In 5/5 patches, application of diazoxide (100 microM) increased significantly P(open) (0.12 +/- 0.02), which was attributable to a twofold increase in the frequency of bursts (8.3 +/- 2.0 Hz). Diazoxide was without effect on tau(open) and tau(closed,fast) but decreased significantly tau(closed,slow) (24.4 +/- 2.6 ms). We observed similar effects in 6/7 patches after exposure to hypoxia/hypoglycemia, which increased significantly P(open) (0.09 +/- 0.03) and the frequency of bursts (7.1 +/- 1.7 Hz) and decreased significantly tau(closed,slow) (29.5 +/- 1.8 ms). We have presented convergent evidence consistent with single K(ATP) channel activity in DG granule cells. The subunit composition of K(ATP) channels native to DG granule cells is not known; however, the characteristics of the channel activity we recorded are representative of Kir6.1/SUR1, SUR2B-based channels.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11067973     DOI: 10.1152/jn.2000.84.5.2291

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  12 in total

Review 1.  KATP Channels in the Cardiovascular System.

Authors:  Monique N Foster; William A Coetzee
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

2.  Forward operation of adenine nucleotide translocase during F0F1-ATPase reversal: critical role of matrix substrate-level phosphorylation.

Authors:  Christos Chinopoulos; Akos A Gerencser; Miklos Mandi; Katalin Mathe; Beata Töröcsik; Judit Doczi; Lilla Turiak; Gergely Kiss; Csaba Konràd; Szilvia Vajda; Viktoria Vereczki; Richard J Oh; Vera Adam-Vizi
Journal:  FASEB J       Date:  2010-03-05       Impact factor: 5.191

3.  T2N as a new tool for robust electrophysiological modeling demonstrated for mature and adult-born dentate granule cells.

Authors:  Hermann Cuntz; Peter Jedlicka; Marcel Beining; Lucas Alberto Mongiat; Stephan Wolfgang Schwarzacher
Journal:  Elife       Date:  2017-11-22       Impact factor: 8.140

4.  Single K ATP channel opening in response to action potential firing in mouse dentate granule neurons.

Authors:  Geoffrey R Tanner; Andrew Lutas; Juan Ramón Martínez-François; Gary Yellen
Journal:  J Neurosci       Date:  2011-06-08       Impact factor: 6.167

5.  Enhanced spontaneous transmitter release is the earliest consequence of neocortical hypoxia that can explain the disruption of normal circuit function.

Authors:  I A Fleidervish; C Gebhardt; N Astman; M J Gutnick; U Heinemann
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

6.  Novel human ABCC9/SUR2 brain-expressed transcripts and an eQTL relevant to hippocampal sclerosis of aging.

Authors:  Peter T Nelson; Wang-Xia Wang; Bernard R Wilfred; Angela Wei; James Dimayuga; Qingwei Huang; Eseosa Ighodaro; Sergey Artiushin; David W Fardo
Journal:  J Neurochem       Date:  2015-07-15       Impact factor: 5.372

7.  Functional characterization of ABCC9 variants identified in sudden unexpected natural death.

Authors:  Ekaterina Subbotina; Hua-Qian Yang; Ivan Gando; Nori Williams; Barbara A Sampson; Yingying Tang; William A Coetzee
Journal:  Forensic Sci Int       Date:  2019-02-27       Impact factor: 2.395

Review 8.  Glibenclamide in cerebral ischemia and stroke.

Authors:  J Marc Simard; Kevin N Sheth; W Taylor Kimberly; Barney J Stern; Gregory J del Zoppo; Sven Jacobson; Volodymyr Gerzanich
Journal:  Neurocrit Care       Date:  2014-04       Impact factor: 3.210

9.  BAD and KATP channels regulate neuron excitability and epileptiform activity.

Authors:  Juan Ramón Martínez-François; María Carmen Fernández-Agüera; Nidhi Nathwani; Carolina Lahmann; Veronica L Burnham; Nika N Danial; Gary Yellen
Journal:  Elife       Date:  2018-01-25       Impact factor: 8.140

Review 10.  Profile of intravenous glyburide for the prevention of cerebral edema following large hemispheric infarction: evidence to date.

Authors:  Zachary A King; Kevin N Sheth; W Taylor Kimberly; J Marc Simard
Journal:  Drug Des Devel Ther       Date:  2018-08-15       Impact factor: 4.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.